Maccura Biotechnology Co.Ltd (SHE:300463)
China · Delayed Price · Currency is CNY 12.15
+0.10 (0.83%)
Feb 4, 2026, 3:12 PM CST
SHE:300463 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Net Income | -117.46 | 126.81 | 312.62 | 708.18 | 956.6 | 793.92 |
Depreciation & Amortization | 334.2 | 334.2 | 313.08 | 270.2 | 236.2 | 205.22 |
Other Amortization | 5.08 | 5.08 | 4.74 | 4.21 | 3.15 | 3.51 |
Loss (Gain) From Sale of Assets | 6.73 | 6.73 | 4.17 | 4.12 | 4.05 | -0.94 |
Asset Writedown & Restructuring Costs | 36.54 | 36.54 | 9.54 | 22.46 | 26.01 | 5.31 |
Loss (Gain) From Sale of Investments | -5.03 | -5.03 | -1.52 | -3.04 | -0.39 | -0.99 |
Provision & Write-off of Bad Debts | -9.92 | -9.92 | 38.27 | 36.26 | 7.76 | 20.36 |
Other Operating Activities | 176.55 | 114.91 | 80.63 | 45.15 | 126.85 | 121.2 |
Change in Accounts Receivable | 127.87 | 127.87 | 214.66 | -277.51 | 257.65 | -162.59 |
Change in Inventory | -0.8 | -0.8 | 11.09 | 15.21 | -19.23 | -240.89 |
Change in Accounts Payable | -77.74 | -77.74 | -51.46 | 47.91 | -45.96 | 369.94 |
Operating Cash Flow | 451.18 | 633.8 | 901.51 | 843.22 | 1,617 | 1,094 |
Operating Cash Flow Growth | -41.96% | -29.70% | 6.91% | -47.84% | 47.77% | 138.09% |
Capital Expenditures | -759.55 | -963.02 | -877.9 | -987.74 | -601.78 | -501.32 |
Sale of Property, Plant & Equipment | 27.41 | 20.81 | 18.18 | 20.25 | 1.95 | 3.8 |
Cash Acquisitions | - | - | - | -164.58 | - | - |
Divestitures | 5.64 | - | -8.69 | - | - | - |
Investment in Securities | 95.01 | 261.86 | 354.79 | -709.72 | -87.5 | -5 |
Other Investing Activities | 9.78 | 2.88 | 10.58 | 11.96 | 0.52 | - |
Investing Cash Flow | -621.71 | -677.47 | -503.04 | -1,830 | -686.81 | -502.52 |
Long-Term Debt Issued | - | 685.9 | 608.75 | 605.13 | 762.97 | 1,057 |
Long-Term Debt Repaid | - | -631.12 | -513.84 | -914.44 | -1,115 | -1,240 |
Net Debt Issued (Repaid) | 254.55 | 54.78 | 94.91 | -309.31 | -352.18 | -183.11 |
Issuance of Common Stock | - | - | - | 1,558 | - | - |
Repurchase of Common Stock | - | - | - | - | -175.43 | -6.49 |
Common Dividends Paid | -84.23 | -115.19 | -244.64 | -318.44 | -296.6 | -105.41 |
Other Financing Activities | -139.3 | -66.37 | -3.02 | -0.62 | -70.49 | -138.36 |
Financing Cash Flow | 31.02 | -126.78 | -152.75 | 930.05 | -894.69 | -433.37 |
Foreign Exchange Rate Adjustments | 0.5 | 0.19 | 1.35 | 5.19 | -2.15 | -5.39 |
Net Cash Flow | -139.01 | -170.26 | 247.07 | -51.38 | 33.02 | 152.76 |
Free Cash Flow | -308.37 | -329.22 | 23.61 | -144.52 | 1,015 | 592.73 |
Free Cash Flow Growth | - | - | - | - | 71.23% | - |
Free Cash Flow Margin | -13.96% | -12.92% | 0.81% | -4.00% | 25.50% | 16.00% |
Free Cash Flow Per Share | -0.51 | -0.54 | 0.04 | -0.24 | 1.82 | 1.06 |
Cash Interest Paid | - | - | - | - | - | 68.19 |
Cash Income Tax Paid | 261.02 | 160.83 | 137.38 | 311.46 | 412.06 | 319.15 |
Levered Free Cash Flow | -310.09 | -208.04 | -54.49 | -410.11 | 404.7 | 254.2 |
Unlevered Free Cash Flow | -296.27 | -194.21 | -33.53 | -388.2 | 441.75 | 296.81 |
Change in Working Capital | 24.48 | 24.48 | 139.98 | -244.32 | 256.45 | -53.54 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.